2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association

被引:73
作者
Choi, Jong Han [1 ]
Lee, Kyung Ae [2 ]
Moon, Joon Ho [3 ]
Chon, Suk [4 ]
Kim, Dae Jung [5 ]
Kim, Hyun Jin [6 ]
Kim, Nan Hee [7 ]
Seo, Ji A. [7 ]
Kim, Mee Kyoung [8 ]
Lim, Jeong Hyun [9 ]
Song, YoonJu [10 ]
Yang, Ye Seul [11 ]
Kim, Jae Hyeon [12 ]
Lee, You-Bin [12 ]
Noh, Junghyun [13 ]
Hur, Kyu Yeon [12 ]
Park, Jong Suk [14 ]
Rhee, Sang Youl [4 ]
Kim, Hae Jin [5 ]
Kim, Hyun Min [15 ]
Ko, Jung Hae [16 ]
Kim, Nam Hoon [17 ]
Kim, Chong Hwa [18 ]
Ahn, Jeeyun [19 ]
Oh, Tae Jung [3 ]
Kim, Soo-Kyung [20 ]
Kim, Jaehyun [21 ]
Han, Eugene [22 ]
Jin, Sang-Man [12 ]
Choi, Won Suk [23 ]
Moon, Min Kyong [24 ]
机构
[1] Konkuk Univ, Med Ctr, Dept Internal Med, Div Endocrinol & Metab,Sch Med, Seoul, South Korea
[2] Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Dept Internal Med, Div Endocrinol & Metab,Med Sch, Jeonju, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea
[4] Kyung Hee Univ, Coll Med, Dept Endocrinol & Metab, Seoul, South Korea
[5] Ajou Univ, Ajou Univ Hosp, Dept Endocrinol & Metab, Sch Med, Suwon, South Korea
[6] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Internal Med, Coll Med, Daejeon, South Korea
[7] Korea Univ, Ansan Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Ansan, South Korea
[8] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,Yeouido St Marys Hosp, Seoul, South Korea
[9] Seoul Natl Univ Hosp, Dept Food Serv & Nutr Care, Seoul, South Korea
[10] Catholic Univ Korea, Dept Food Sci & Nutr, Bucheon, South Korea
[11] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[12] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Endocrinol & Metab,Sch Med, Seoul, South Korea
[13] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Goyang, South Korea
[14] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seoul, South Korea
[15] Chung Ang Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med, Seoul, South Korea
[16] Inje Univ, Haeundae Paik Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Busan, South Korea
[17] Korea Univ, Anam Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Seoul, South Korea
[18] Sejong Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Bucheon, South Korea
[19] Seoul Natl Univ, Seoul Metropolitan Govt Seoul Natl Univ Boramae M, Dept Ophthalmol, Coll Med, Seoul, South Korea
[20] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Div Endocrinol & Metab,Sch Med, Seongnam, South Korea
[21] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Coll Med, Seongnam, South Korea
[22] Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea
[23] Korea Univ, Ansan Hosp, Dept Internal Med, Div Infect Dis,Coll Med, Ansan, South Korea
[24] Seoul Natl Univ, Seoul Metropolitan Govt Seoul Natl Univ Boramae M, Dept Internal Med, Coll Med, 20 Boramae Ro 5 Gil, Seoul 07061, South Korea
关键词
Diabetes mellitus; Practice guideline; Prediabetic state; Republic of Korea; FATTY LIVER-DISEASE; FIXED-RATIO COMBINATION; INTENSIVE INSULIN THERAPY; PEPTIDE-1 RECEPTOR AGONIST; GLUCOSE-SENSING TECHNOLOGY; GLARGINE PLUS LIXISENATIDE; ONCE-DAILY LIXISENATIDE; BLOOD-PRESSURE CONTROL; CHRONIC KIDNEY-DISEASE; BASAL INSULIN;
D O I
10.4093/dmj.2023.0282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In May 2023, the Committee of Clinical Practice Guidelines of the Korean Diabetes Association published the revised clinical practice guidelines for Korean adults with diabetes and prediabetes. We incorporated the latest clinical research findings through a comprehensive systematic literature review and applied them in a manner suitable for the Korean population. These guidelines are designed for all healthcare providers nationwide, including physicians, diabetes experts, and certified diabetes educators who manage patients with diabetes or individuals at risk of developing diabetes. Based on recent changes in international guidelines and the results of a Korean epidemiological study, the recommended age for diabetes screening has been lowered. In collaboration with the relevant Korean medical societies, recently revised guidelines for managing hypertension and dyslipidemia in patients with diabetes have been incorporated into this guideline. An abridgment containing practical information on patient education and systematic management in the clinic was published separately.
引用
收藏
页码:575 / 594
页数:20
相关论文
共 141 条
[1]   Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis [J].
Agarwal, Rajiv ;
Filippatos, Gerasimos ;
Pitt, Bertram ;
Anker, Stefan D. ;
Rossing, Peter ;
Joseph, Amer ;
Kolkhof, Peter ;
Nowack, Christina ;
Gebel, Martin ;
Ruilope, Luis M. ;
Bakris, George L. .
EUROPEAN HEART JOURNAL, 2022, 43 (06) :474-+
[2]   Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial [J].
Ahmann, A. ;
Rodbard, H. W. ;
Rosenstock, J. ;
Lahtela, J. T. ;
de Loredo, L. ;
Tornoe, K. ;
Boopalan, A. ;
Nauck, M. A. .
DIABETES OBESITY & METABOLISM, 2015, 17 (11) :1056-1064
[3]   Acute coronary syndromes and diabetes: is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial [J].
Ahmed, Shaheeda ;
Cannon, Christopher P. ;
Murphy, Sabina A. ;
Braunwald, Eugene .
EUROPEAN HEART JOURNAL, 2006, 27 (19) :2323-2329
[4]   Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].
Anker, Stefan D. ;
Butler, Javed ;
Filippatos, Gerasimos ;
Ferreira, Joao P. ;
Bocchi, Edimar ;
Boehm, Michael ;
Brunner-La Rocca, Hans-Peter ;
Choi, Dong-Ju ;
Chopra, Vijay ;
Chuquiure-Valenzuela, Eduardo ;
Giannetti, Nadia ;
Gomez-Mesa, Juan Esteban ;
Janssens, Stefan ;
Januzzi, James L. ;
Gonzalez-Juanatey, Jose R. ;
Merkely, Bela ;
Nicholls, Stephen J. ;
Perrone, Sergio V. ;
Pina, Ileana L. ;
Ponikowski, Piotr ;
Senni, Michele ;
Sim, David ;
Spinar, Jindrich ;
Squire, Iain ;
Taddei, Stefano ;
Tsutsui, Hiroyuki ;
Verma, Subodh ;
Vinereanu, Dragos ;
Zhang, Jian ;
Carson, Peter ;
Lam, Carolyn Su Ping ;
Marx, Nikolaus ;
Zeller, Cordula ;
Sattar, Naveed ;
Jamal, Waheed ;
Schnaidt, Sven ;
Schnee, Janet M. ;
Brueckmann, Martina ;
Pocock, Stuart J. ;
Zannad, Faiez ;
Packer, Milton .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461
[5]   Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus A Scientific Statement From the American Heart Association [J].
Arnold, Suzanne, V ;
Bhatt, Deepak L. ;
Barsness, Gregory W. ;
Beatty, Alexis L. ;
Deedwania, Prakash C. ;
Inzucchi, Silvio E. ;
Kosiborod, Mikhail ;
Leiter, Lawrence A. ;
Lipska, Kasia J. ;
Newman, Jonathan D. ;
Welty, Francine K. .
CIRCULATION, 2020, 141 (19) :E779-E806
[6]   Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study) [J].
Aroda, V. R. ;
Bailey, T. S. ;
Cariou, B. ;
Kumar, S. ;
Leiter, L. A. ;
Raskin, P. ;
Zacho, J. ;
Andersen, T. H. ;
Philis-Tsimikas, A. .
DIABETES OBESITY & METABOLISM, 2016, 18 (07) :663-670
[7]   Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial [J].
Aroda, Vanita R. ;
Rosenstock, Julio ;
Wysham, Carol ;
Unger, Jeffrey ;
Bellido, Diego ;
Gonzalez-Galvez, Guillermo ;
Takami, Akane ;
Guo, Hailing ;
Niemoeller, Elisabeth ;
Souhami, Elisabeth ;
Bergenstal, Richard M. .
DIABETES CARE, 2016, 39 (11) :1972-1980
[8]  
Bae JH, 2022, DIABETES METAB J, V46, P417
[9]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[10]   Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes [J].
Bakris, George L. ;
Agarwal, Rajiv ;
Anker, Stefan D. ;
Pitt, Bertram ;
Ruilope, Luis M. ;
Rossing, Peter ;
Kolkhof, Peter ;
Nowack, Christina ;
Schloemer, Patrick ;
Joseph, Amer ;
Filippatos, Gerasimos .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) :2219-2229